Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
The pathophysiology of factor H-associated HUS was analysed.
|
14564205 |
2003 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Results of previous studies on HF1 indicate an association between HF1 deficiency and D-HUS.
|
14615110 |
2003 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality.
|
12836093 |
2003 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.
|
14583443 |
2003 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
These defective features of the mutant factor H proteins explain progression of endothelial cell and microvascular damage in factor H-associated genetic HUS and indicate a protective role of factor H for tissue integrity during thrombus formation.
|
12697737 |
2003 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
In conclusion, although APOLT showed clinical and laboratory improvement for some period in this patient, the final fatal outcome suggests that liver transplantation should be cautiously applied to patients with HUS associated with FH deficiency.
|
14986080 |
2004 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Data obtained from HUS patients and control individuals indicate that this assay is a useful tool for the molecular diagnosis of factor H-related HUS.
|
15140578 |
2004 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The HF-1 gene encodes complement factor H and the mutation leads to the insertion of 12 additional amino acids after codon 1176 in factor H. The recurrent HUS responded to plasma infusions and renal function improved from a glomerular filtration rate of 21 to 50 ml/min per 1.73 m(2).
|
15206027 |
2004 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Four children with homozygous or heterozygous FH deficiency and HUS underwent renal transplantation, which was successful in three but failed as a result of recurrence of HUS in one patient.
|
14978182 |
2004 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Factor H mutations have been described in 15-30% of patients with atypical haemolytic uraemic syndrome (HUS).
|
15121049 |
2004 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
This case indicates that more fundamental research is needed before combined liver and kidney transplant is considered an option for children with HF-1-associated HUS.
|
15816899 |
2005 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The feasibility of kidney transplantation in case of atypical HUS related to factor H mutation using continuous prophylactic PE intensified during relapses should be confirmed in prospective studies.
|
15696434 |
2005 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome.
|
16470555 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
|
16386793 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In order to identify the structural and functional consequence of HUS mutations, further disease-associated mutations were analyzed in terms of homology and nuclear magnetic resonance (NMR) models for factor H SCR domains.
|
16281287 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
A heterozygous mutation in CCP 20 of factor H was found in a girl with HUS.
|
16528247 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
This report suggests that despite setbacks in previous experience, combined liver-kidney transplantation offers the prospect of a favorable long-term outcome for patients with HUS associated with complement factor H mutations.
|
16889549 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
A user's guide to the interactive Web database of factor H-associated hemolytic uremic syndrome.
|
16575691 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This report suggests that despite setbacks in previous experience, combined liver-kidney transplantation offers the prospect of a favorable long-term outcome for patients with HUS associated with complement factor H mutations.
|
16889549 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
So far, mutations in single genes coding for the cofactor and complement regulator factor H, the membrane cofactor protein (MCP/CD46), the serine protease factor I, and autoantibodies to factor H have been linked to HUS.
|
16575689 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
MCP-HUS has a better prognosis and a better outcome after transplantation than either CFH-HUS or IF-HUS.
|
16968692 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.
|
17076561 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A heterozygous mutation in CCP 20 of factor H was found in a girl with HUS.
|
16528247 |
2006 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
|
17495132 |
2007 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
|
17599974 |
2007 |